JG
ALNY icon

Jefferies Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Jefferies Group’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$11M Buy
54,800
+35,000
+177% +$6.68M 0.09% 170
2022
Q2 		$2.89M Buy
+19,800
New +$2.81M 0.02% 507
2021
Q2 		– Sell
-5,000
Closed -$706K – 1637
2021
Q1 		$706K Sell
5,000
-9,400
-65% -$1.41M 0.01% 1011
2020
Q4 		$1.87M Buy
+14,400
New +$1.92M 0.01% 734
2020
Q2 		– Sell
-80,000
Closed -$8.71M – 1277
2020
Q1 		$8.71M Buy
+80,000
New +$9.23M 0.1% 182
2019
Q4 		– Sell
-15,000
Closed -$1.21M – 2532
2019
Q3 		$1.21M Buy
+15,000
New +$1.19M 0.01% 1405
2018
Q4 		– Sell
-35,700
Closed -$3.12M – 2128
2018
Q3 		$3.12M Buy
35,700
+16,300
+84% +$1.64M 0.02% 767
2018
Q2 		$1.91M Buy
19,400
+14,400
+288% +$1.43M 0.01% 917
2018
Q1 		$596K Sell
5,000
-4,000
-44% -$516K ﹤0.01% 1411
2017
Q4 		$1.14M Sell
9,000
-185,500
-95% -$23.3M 0.01% 1276
2017
Q3 		$22.9M Buy
+194,500
New +$16.6M 0.15% 103
2016
Q3 		– Sell
-12,700
Closed -$705K – 2198
2016
Q2 		$705K Buy
+12,700
New +$800K ﹤0.01% 1280
2016
Q1 		– Sell
-16,100
Closed -$1.52M – 2171
2015
Q4 		$1.52M Buy
+16,100
New +$1.49M 0.01% 990
2014
Q2 		– Sell
-47,600
Closed -$3.2M – 2043
2014
Q1 		$3.2M Buy
+47,600
New +$3.69M 0.03% 450

Other funds holding ALNY

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Jefferies Group's ALNY Position: Q3 2022 in Review

Jefferies Group increased its Alnylam Pharmaceuticals (ALNY) stake by 177% in Q3 2022, buying an estimated $5.69M and bringing the position to 46,726 shares worth $9.35M. The position accounts for 0.08% of the portfolio, ranked #202.

Jefferies Group first reported a position in ALNY in Q2 2013 and has held it in 24 quarters since. 496 funds tracked by Wall St. Rank hold ALNY as of Q3 2022.

  • Jefferies Group held 46,726 shares of Alnylam Pharmaceuticals worth $9.35M as of Q3 2022.
  • Jefferies Group bought 29,831 Alnylam Pharmaceuticals shares in Q3 2022, an estimated $5.69M.
  • Alnylam Pharmaceuticals made up 0.08% of Jefferies Group's portfolio in Q3 2022, its #202 holding.
  • Jefferies Group first reported a position in Alnylam Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
  • 496 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.